About Us

Our commitment is to provide support for early-stage drug discovery and translating academic innovations into new drug candidates

About Us
Providing support for early-stage drug discovery. BCDD

The BLAVATNIK CENTER for Drug Discovery (BCDD) is a fully integrated center for translational research, based at Tel Aviv University, that comprises medicinal chemistry, biological target identification and computer-assisted drug design units under one roof.

 

The (BCDD) is the first complex of this kind at an Israeli university, and provides a state-of-the-art R&D environment and academic platform in the relevant fields of early stage drug discovery.

 

Our Mission

The BCDD’s commitment is to provide support for early-stage drug discovery and translating academic innovations into new drug candidates.

 

The BCDD provides the academic environment, expertise, and infrastructure to help researchers develop disease models/biological assays for drug screening and to advance promising early-stage drug candidates through the optimization/target validation pipeline.

 

Our Uniqeness

  • Early-Stage Drug Discovery - Top-of-the-line and one of a kind academic platform for campaigns
  • Treatments for Rare Diseases - By preforms translational innovative research

  • Personalized Medicine - cell-based HTS platform derived from patients samples

  • Automated Infrastructure - Cutting edge and research methodologies

  • Academic R&D - To reach industrial requirements

Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained
here and / or the use of such content is in your opinion infringing, Contact us as soon as possible >>